1. Home
  2. ROG vs PCRX Comparison

ROG vs PCRX Comparison

Compare ROG & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROG
  • PCRX
  • Stock Information
  • Founded
  • ROG 1832
  • PCRX 2006
  • Country
  • ROG United States
  • PCRX United States
  • Employees
  • ROG N/A
  • PCRX N/A
  • Industry
  • ROG Industrial Machinery/Components
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROG Technology
  • PCRX Health Care
  • Exchange
  • ROG Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • ROG 1.3B
  • PCRX 1.2B
  • IPO Year
  • ROG N/A
  • PCRX 2011
  • Fundamental
  • Price
  • ROG $68.66
  • PCRX $24.02
  • Analyst Decision
  • ROG Strong Buy
  • PCRX Buy
  • Analyst Count
  • ROG 2
  • PCRX 9
  • Target Price
  • ROG $85.00
  • PCRX $29.89
  • AVG Volume (30 Days)
  • ROG 156.8K
  • PCRX 526.9K
  • Earning Date
  • ROG 07-24-2025
  • PCRX 07-29-2025
  • Dividend Yield
  • ROG N/A
  • PCRX N/A
  • EPS Growth
  • ROG N/A
  • PCRX N/A
  • EPS
  • ROG 0.90
  • PCRX N/A
  • Revenue
  • ROG $807,200,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • ROG N/A
  • PCRX $7.54
  • Revenue Next Year
  • ROG $8.37
  • PCRX $10.78
  • P/E Ratio
  • ROG $76.16
  • PCRX N/A
  • Revenue Growth
  • ROG N/A
  • PCRX 3.08
  • 52 Week Low
  • ROG $51.43
  • PCRX $11.16
  • 52 Week High
  • ROG $134.07
  • PCRX $29.33
  • Technical
  • Relative Strength Index (RSI)
  • ROG 54.75
  • PCRX 36.83
  • Support Level
  • ROG $67.83
  • PCRX $23.85
  • Resistance Level
  • ROG $69.81
  • PCRX $25.16
  • Average True Range (ATR)
  • ROG 1.81
  • PCRX 0.79
  • MACD
  • ROG -0.13
  • PCRX -0.12
  • Stochastic Oscillator
  • ROG 61.20
  • PCRX 8.20

About ROG Rogers Corporation

Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: